Navigation Links
Safest painkiller Ibuprofen found to cause severe GI bleeding

Gastrointestinal bleeding is three times more likely to occur in patients who take high doses of ibuprofen on a regular basis despite the safety profile of non-steroidal anti-inflammatory drugs (NSAIDs). // Furthermore, the effect can be observed as early as three days after starting an ibuprofen regimen.

Ibuprofen is considered to have one of the most favorable safety profiles of all of the traditional non-selective NSAIDs, touted as the painkiller with the fewest side effects and lowest incidence of ulcers or GI bleeding.

Researchers have expressed concern over people with chronic pain such as arthritis who often increase the recommended dose of their painkillers. They should be made aware of the fact that it can have adverse effects with respect to the gastrointestinal tract.

Of all the NSAIDs available over-the-counter, ibuprofen is regarded to have the least harmful effects on the GI tract. However, the study shows that healthy, young people and older people are at great risk of internal bleeding and should speak with their doctor to determine the risks of taking large amounts of ibuprofen.

The study included 68 healthy volunteers who were given either four weeks of an ibuprofen regimen or a placebo. Prior to starting the regimen, patients were evaluated for a one-week control period to demonstrate that they were not bleeding.

It was found that those taking ibuprofen for 28 days experienced blood loss that was 3.64-fold greater than the placebo group. On average, those taking ibuprofen experienced blood loss as low as 40mL and as high as 299mL. Other side effects anemia and other adverse events can be observed at any dose of ibuprofen.

It is hoped that these findings will bring attention to the reality of the amount of painkillers potentially being used by patients at home.


'"/>




Page: 1

Related medicine news :

1. Breast Milk Safest For Child Till Six Months of Age
2. Drug dilemma confronts users of painkillers
3. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
4. Codeine-based painkillers to be used cautiously
5. Ibuprofen weakens aspirins effect
6. Ibuprofen to lower risk of Parkinson’s diseas
7. Use Of Ibuprofen Safe For Short Periods
8. Ibuprofen and Vitamins C and E Could Halt Alzheimers
9. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
10. Children Find Effective Pain Relief With Ibuprofen
11. Ibuprofen Risky for Heart Patients?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... 2017 , ... “End Time GPS”: a dauntless and enlightened study of ... GPS” is the creation of published author, Wesley Gerboth, a World War II veteran, ... space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon him ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
(Date:3/24/2017)... Global Ampoules Market report provides ... applications and industry chain structure. The Ampoules market analysis ... competitive landscape analysis, and major regions, development status. ... ... providing 10 company profiles and 183 tables and figures ...
(Date:3/24/2017)... March 24, 2017  GenomeDx Biosciences today announced that ... and Decipher® Prostate Cancer Classifier tests will be presented ... Urology (EAU) Congress held March 24 to 28, 2017 ... EAU Congress is Europe,s largest ... in the urological field. The abstract titled ...
Breaking Medicine Technology: